ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,487.03
      0.25%
      US Tech 100
      19,430.40
      0.14%
      Dow Jones
      38,834.86
      0.15%
      Brent Oil
      84.545
      -0.18%
      Bitcoin
      65,127.11
      0.25%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. GeoVax Labs Inc (GOVXW)

      7. GeoVax Labs Inc (GOVXW) News

      GOVXW GeoVax Labs Inc

      0.067
      0.0402 (150.00%)
      Jun 18 2024 - Closed
      Delayed by 15 minutes
      Company Name Stock Ticker Symbol Market Type
      GeoVax Labs Inc GOVXW NASDAQ Equity Warrant
        Price Change Change Percent Stock Price Last Traded
      Upgrade Icon
      0.0402 150.00% 0.067 20:00:00
      Open Price Low Price High Price Close Price Prev Close
      0.0302 0.0302 0.056449 0.0532 0.0268
      more quote information »

      Recent News

      Date Time Source Heading
      6/18/202413:13EDGAR2Form 8-K - Current report
      6/07/202416:01EDGAR2Form S-1 - General form for registration of securities under..
      5/24/202416:04EDGAR2Form 8-K - Current report
      5/23/202416:07EDGAR2Form 8-K - Current report
      5/21/202417:23EDGAR2Form 8-K - Current report
      5/21/202412:32EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
      5/15/202416:03EDGAR2Form 8-K - Current report
      5/14/202417:09EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
      5/14/202417:09EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
      5/14/202417:08EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
      5/14/202417:07EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
      5/14/202416:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
      4/04/202412:30GLOBEGeoVax Presents Data on GEO-CM04S1, a Next Generation..
      3/28/202409:00GLOBEGeoVax to Present Data on GEO-CM04S1, a Next Generation..
      3/12/202409:00GLOBEGeoVax to Present at the 36th Annual Roth Conference
      3/06/202409:00GLOBEGeoVax Achieves Milestone in Transition to Commercially..
      2/29/202416:00GLOBEGeoVax Reports 2023 Year-End Financial Results and Provides..
      2/22/202409:00GLOBEGeoVax to Report 2023 Financial Results and Provide..
      2/19/202409:00GLOBEGeoVax to Present at the 2024 BIO CEO & Investor Conference
      2/13/202409:00GLOBEGeoVax Announces Multiple Patent Issuances and Allowances
      2/06/202409:00GLOBEGeoVax Reports Positive Interim Data From Phase 2 Clinical..
      1/29/202409:00GLOBEGeoVax Announces 1-for-15 Reverse Stock Split to Regain..
      1/08/202409:00GLOBEGeoVax Appoints Dr. Marc Pipas as Executive Medical..
      1/04/202409:00GLOBEGeoVax Announces Gedeptin® Patient Enrollment Closure for..
      1/03/202409:00GLOBEGeoVax Announces Issuance of Malaria Vaccine Patent
      12/27/202309:00GLOBEGeoVax to Present at Biotech Showcase During J.P. Morgan..
      12/19/202309:00GLOBEGeoVax Expands Rights Under NIH COVID-19 License to Include..
      11/30/202316:30GLOBEGeoVax Hemorrhagic Fever Vaccine Data Presented at World..
      11/29/202309:00GLOBEGeoVax to Participate in Upcoming December Investor Events
      11/28/202309:00GLOBEGeoVax COVID-19 Vaccine Clinical Data Presented at World..
      11/14/202309:00GLOBEProgress on GeoVax’s Universal Coronavirus Vaccine..
      11/08/202316:00GLOBEGeoVax Reports Third Quarter 2023 Financial Results and..
      10/31/202309:00GLOBEGeoVax to Report Third Quarter 2023 Financial Results and..
      10/30/202309:00GLOBEGeoVax Commences Site Expansion for Phase 2 Trial of..
      10/25/202309:00GLOBEGeoVax to Participate in Upcoming November Investor and..
      10/24/202309:00GLOBEGeoVax Update: Clinical and Operational Progress Toward..
      10/09/202309:00GLOBEGeoVax Receives Notice of Allowance for Marburg Vaccine..
      10/05/202309:00GLOBEGeoVax Receives Notice of Allowance for HIV Vaccine Patent
      9/27/202309:00GLOBEGeoVax to Participate in Upcoming October Investor and..
      9/26/202309:00GLOBEGeoVax Secures Multi-Product License for ProBioGen's..
      9/20/202309:00GLOBEGeoVax Next-Generation COVID-19 Vaccine Data Presented at..
      9/19/202309:00GLOBEGeoVax Next-Generation COVID-19 Vaccine Demonstrates Potent..
      9/12/202309:00GLOBEGeoVax Presents Corporate Update at the H.C. Wainwright 25th..
      9/11/202309:00GLOBEGeoVax Completes Enrollment of Phase 2 Trial for..
      8/31/202309:00GLOBEGeoVax to Present at the H.C. Wainwright 25th Annual Global..
      8/28/202309:00GLOBEGeoVax Receives Notice of Allowance for Malaria Vaccine..
      8/10/202309:00GLOBEGeoVax Announces First Patients Vaccinated in Phase 2..
      8/09/202316:00GLOBEGeoVax Reports 2023 Second Quarter Financial Results and..
      7/26/202309:00GLOBEGeoVax to Report Second Quarter 2023 Financial Results and..
      7/24/202309:00GLOBEGeoVax Announces Issuance of Ebola Vaccine Patent

      Your Recent History

      NASDAQ
      GOVXW
      GeoVax Labs
      USOTC
      RYAOF
      Ryanair (PK)
      BIT
      P12V88
      BNP PARIBAS ISSUANCE
      KOSPI
      032560
      Hang Kum Steel and Techn...
      TSXV
      SNI.PR.A
      Sonor Investments
      Delayed Upgrade Clock